Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

28.98
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
24.82
Today|||52-Week Range
41.20
+0.49%
Year-to-Date

Today’s Trading

Previous close28.98
Today’s open29.18
Day’s range28.85 - 29.57
Volume1,642,497
Average volume (3 months)1,529,261
Market cap$3.5B
Data as of 4:15pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)-43.56%
Earnings growth (this year)-3.38%
Earnings growth (next 5 years)+38.29%
Revenue growth (last year)+28,311.48%
P/E ratioNM
Price/Sales192.80
Price/Book6.78

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...0.000.00%
AKRXAkorn Inc0.000.00%
AGNPRAAllergan plc0.000.00%
MNKMallinckrodt Plc0.000.00%
Data as of 4:05pm ET, 12/15/2017

Financials

Next reporting dateMarch 1, 2018
EPS forecast (this quarter)-$0.58
Annual revenue (last year)$17.3M
Annual profit (last year)-$271.4M
Net profit margin-1,565.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Senior VP-Technology Development &
Operations
James A. Nash
Corporate headquarters
San Diego, California

Forecasts